Jill Buck

Jill Buck has extensive experience in clinical development and operations, having held key leadership positions at several notable organizations. Most recently, Jill served as Chief Development Officer at enGene in July 2025 and previously as Senior Vice President of Clinical Development Operations in Massachusetts. Jill's career includes roles such as Head of Clinical Development Operations at Albireo, and various leadership positions at Millennium Pharmaceuticals, Ziopharm Oncology, and Synageva BioPharma Corp. Jill's early career involved roles at Averion Inc. and Control Delivery Systems, contributing to a robust background in clinical affairs and data services. Jill's educational background includes studies at Boston College and Groton School.